Inactive Instrument

Ocata Therapeutics Inc Stock OTC Bulletin Board

Equities

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	16-02-10	PR
Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	16-01-22	PR
Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	15-12-28	BU
Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	15-12-03	BU
OCATA THERAPEUTICS : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Astellas Pharma Inc.	15-11-11	BU

Managers	Title	Age	Since
Yoshitsuga Shitaka PSD	President	-	-
John Heffernan PRN	Corporate Officer/Principal	-	15-02-02

Members of the board	Title	Age	Since
Percival Barretto-Ko BRD	Director/Board Member	51	-
Masaaki Hirano BRD	Director/Board Member	57	-
Toru Yoshimitsu BRD	Director/Board Member	61	-

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+5.33%	111B
REGENERON PHARMACEUTICALS, INC.	+12.11%	106B
BIONTECH SE	-12.56%	22.24B
ARGENX SE	-3.70%	21.25B
GENMAB A/S	-6.03%	18.97B
WUXI APPTEC CO., LTD.	-35.21%	18.52B
BEIGENE, LTD.	-10.86%	16.81B
NEUROCRINE BIOSCIENCES, INC.	+5.10%	13.94B
SAREPTA THERAPEUTICS, INC.	+37.57%	12.54B